response was lower in ACD than in iron deficient patients. It was concluded that generally more than one type of anaemia is present simultaneously in anaemic patients with RA. The diagnosis of each type may be masked by another. Studies on pathogenesis of the anaemia are difficult as deficiencies generally coexist with ACD. Disease activity and, possibly, erythropoietin responsiveness are major factors in ACD pathogenesis.
In patients with active rheumatoid arthritis (RA) anaemia is often present.' 2 Many types of anaemia are associated with active RA. Vitamin B12 and folic acid deficiency are reported to be more prevalent among patients with RA than controls.3 ' The prevalence of iron deficiency is up to 50-70% in RA.5 6 Many patients with active RA also have the anaemia of chronic disease (ACD) originally described by Cartwright and Lee.7 Controversial theories exist about the pathogenesis of ACD, including decreased iron absorption,8 9 iron release by the mononuclear phagocyte system,'0 1" and erythropoietin deficiency. '2 13 In patients with active RA several causes of anaemia, associated with RA, may be present simultaneously, making studies on diagnosis and pathogenesis difficult to interpret. We therefore performed a study to assess the prevalence of iron, vitamin B12, and folic acid deficiency among patients with RA with and without ACD to determine whether such deficiencies are commonly masked and to establish the role ofiron absorption and erythropoietin response in ACD with or without these deficiencies.
Patients and methods

PATIENTS
Thirty six patients (five male) with definite or classical rheumatoid arthritis were studied. Patients who had recently been treated with iron, folic acid, or vitamin B12 were excluded. Patients with a present or past history of ulcers, hypermenorrhoea, haematuria, positive stools for occult blood, haemolysis, or decreased creatinine clearance were also excluded.
Overall disease duration was seven years and 22 (61%) of the patients used longacting antirheumatic drugs while 30 Table 2 : Effect of low serum vitamin B,2 (<150 pmolll) and low serum folic acid (<7 nmolll) on cellular indices in non-anaemic patients (I), iron deficient patients (II), and patients with the anaemia of chronic disease (III). indices are commonly found.6 7 19 Vitamin B12 deficiency is usually associated with a hyperchromic macrocytic anaemia. 3 Iron deficiency is associated with a hypochromic microcytic anaemia'7 so the combination results in normal indices. Folic acid deficiency exerted the same effects on cellular indices, but these were not significant.
Serum iron concentration was below normal in all patients, including the non-anaemic patients, though it was lower in both anaemic groups. It is known that serum iron does not distinguish between iron deficiency and ACD,7 21 which implies that it does not correlate with body iron stores. The low serum iron in non-anaemic patients might be explained by the fact that in chronic disease, to some extent also present in this group, serum iron is low, possibly throiugh trapping by ferritin2' or the mononuclear phagocyte system.' 11 It was shown that in most patients with RA several causes of anaemia were present simultaneously. We assume that iron deficient patients also have features of ACD as a negative correlation was found between haemoglobin concentration and disease activity (ESR) in the group with ACD, and indices of disease activity were higher in iron deficient patients than in nonanaemic patients. This assumption was confirmed by the lower transferrin concentration in iron deficient patients than in non-anaemic patients, though ferritin concentration was not low in either non-anaemic or iron deficient patients, but transferrin concentration was lowest and ferritin concentration highest in patients with ACD. Ferritin behaves like an acute phase reactant24 25 as it correlates with ESR and CRP. Among patients with ACD iron deficiency can be detected most easily by means of the lower ferritin concentration, though it is not subnormal. Other studies have suggested raising the cut off point to 60 Rg/l5 to detect iron deficiency.
The dichotomy ACD versus iron deficiency, therefore, is artificial because in fact it is a combination. Thus we found that only .8/25 (32%) anaemic patients with RA had just one cause of anaemia (ACD).
All other patients had combinations of iron, vitamin B12, or folic acid deficiency, with or without ACD. In two patients (8%) both folic acid and vitamin B12 deficiency occurred. This implies not only that accurate diagnostic attention should be paid to the approach of anaemic patients with RA but also that several therapeutic possibilities in the treatment of anaemia in RA are present apart from treating the RA.
PATHOGENETIC ASPECTS
Iron deficiency
We found iron deficiency in 13/25 (52%) of anaemic patients with RA, which is in agreement with findings of other authors, who found a prevalence of 50-70%.' 6 Although in our study patients with gastrointestinal disease and positive stools for occult blood were excluded, gastrointestinal lesions and blood loss can occur subclinically and intermittendy.26 27 It is important to rule out gastrointestinal blood loss in patients with RA. It was recently found that cellular indices and ferritin did not differ in anaemic patients with RA with or without gastrointestinal lesions.28 Thus selection of anaemic patients with RA for gastrointestinal tract investigation remains difficult.
In our study iron absorption measured by a simple, non-invasive test tended to be higher in iron deficient patients with RA than in nonanaemic patients and patients with ACD. It correlated negatively with indices of disease activity, particularly in the non-anaemic group. Other authors, using radiolabelled 59Fe absorption studies, showed that iron absorption is lower in active RA. Iron absorption in iron deficient patients with active RA is higher than in those with ACD but lower than in iron deficient patients without chronic disease.9 29 It may be concluded that decreased iron absorption is the result of active RA and not a cause of ACD or iron deficiency in RA.
Vitamin B12 deficiency
We found vitamin B12 deficiency in 7/24 (29%) of the patients with RA. As the prevalence was the same in non-anaemic patients its role as a cause of anaemia in RA becomes less clear. It was recently shown, however, that vitamin B12 deficiency can be present without anaemia or the typical change in indices,30 but this was found in a minority of vitamin B12 deficient patients. Overall serum vitamin B12 tended to be lower in the anaemic patients, particularly in the patients with ACD, median vitamin B12 concentration being just above the lower limit (150 pmol/l). Schilling tests were normal in most patients, which was also found by Couchman et al. 3 We found a normal prevalence of gastric antibodies and pernicious anaemia in our patients, in contrast with others,3 31 who found an increased prevalence. This difference is probably due to the small number of patients studied here. Thus vitamin B12 deficiency is high among patients with RA, but its cause remains to be established.
Folic acid deficiency Folic acid deficiency was seen most often in iron deficient patients. Serum folic acid concentration was significantly lower in the anaemic than in the non-anaemic patients. Cough et al found a low serum folic acid concentration in 65% of the patients with RA (cut off point 6 nmol/1). 32 In that study no specific causes were found either. The coexistence with iron deficiency suggests either malabsorption, which was not found, or dietary causes. We found a negative correlation between serum folic acid, ESR and CRP, suggesting lower concentrations in active RA. It is not entirely clear whether low serum folic acid has a causative role in ACD or whether active RA, associated with ACD, produces a secondary low serum folic acid concentration as folic acid concentration was normal in non-anaemic patients. Anorexia due to active RA or increased use by proliferating synovial cells32 3 
